Spyre Therapeutics Inc <SYRE.O>: Jefferies cuts target price to $125 from $130
SYRE•Related News
Gulf ship traffic via Strait of Hormuz hovers below 10-day average, data shows
XLE•
Markets are waiting '9 to 5'
SPY•
Abrdn Total Dynamic Dividend Fund Enters Distribution Agreement With Alps Distributors On August 25, 2026 - SEC Filing
AOD•
Box Inc <BOX.N>: Raymond James Raises Target Price to $40 From $32
BOX•
US Cash Crude-Grades mixed on final day of cash roll period
XOM•